Cargando…
Reversal Strategies for Intracranial Hemorrhage Related to Direct Oral Anticoagulant Medications
Direct oral anticoagulants (DOACs) are a new class of anticoagulants that directly inhibit either thrombin or factor Xa in the coagulation cascade. They are being increasingly used instead of warfarin or other vitamin K antagonists (VKAs). Adverse side effects of DOACs may result in hemorrhagic comp...
Autores principales: | Dabi, Alok, Koutrouvelis, Aristides P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057345/ https://www.ncbi.nlm.nih.gov/pubmed/30073093 http://dx.doi.org/10.1155/2018/4907164 |
Ejemplares similares
-
Evaluation of Direct Oral Anticoagulant Reversal Agents in Intracranial Hemorrhage: A Systematic Review and Meta-analysis
por: Chaudhary, Rahul, et al.
Publicado: (2022) -
Reversal of direct oral anticoagulants
por: Almegren, Mosaad
Publicado: (2017) -
Reversal of oral anticoagulation in patients with acute intracerebral hemorrhage
por: Kuramatsu, Joji B., et al.
Publicado: (2019) -
Anticoagulation Holiday: Resumption of Direct Oral Anticoagulants for Atrial Fibrillation in Patients with Index Traumatic Intracranial Hemorrhage
por: Ghenbot, Yohannes, et al.
Publicado: (2022) -
Management of anticoagulant-related intracranial hemorrhage: an evidence-based review
por: Ray, Bappaditya, et al.
Publicado: (2014)